About Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
During the past decade, Nycomed Japan and Mitsubishi Tanabe Pharma Corporation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nycomed Japan and Mitsubishi Tanabe Pharma Corporation"
#1 collaborator was "Mitsubishi Tanabe Pharma Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
According to Clinical.Site data, the most researched conditions in "Nycomed Japan and Mitsubishi Tanabe Pharma Corporation" are
"Bronchial Asthma" (2 trials). Many other conditions were trialed in "Nycomed Japan and Mitsubishi Tanabe Pharma Corporation" in a lesser frequency.
Clinical Trials Intervention Types at Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
Most popular intervention types in "Nycomed Japan and Mitsubishi Tanabe Pharma Corporation" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Roflumilast" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
The vast majority of trials in "Nycomed Japan and Mitsubishi Tanabe Pharma Corporation" are
2 trials for "All" genders.
Clinical Trials Status at Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
Currently, there are NaN active trials in "Nycomed Japan and Mitsubishi Tanabe Pharma Corporation".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Nycomed Japan and Mitsubishi Tanabe Pharma Corporation,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nycomed Japan and Mitsubishi Tanabe Pharma Corporation, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".